Eczema drug trial halted early: what we know
NCT ID NCT05859724
First seen Jan 23, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This study tested a new drug called NM26-2198 for moderate-to-severe eczema (atopic dermatitis). It included healthy volunteers and patients, giving single or multiple doses to check safety and how the body processes the drug. The trial was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
COPERNICUS Podmiot Leczniczy Sp. z o.o., Szpital Sw. Wojciecha
Gdansk, 80-462, Poland
-
California Clinical Trials Medical Group (CCTMG) managed by Parexel
Glendale, California, 91206, United States
-
Centre de Recherche Saint-Louis
Québec, G1W4R4, Canada
-
D&H Tamarac Research Center
Tamarac, Florida, 33321, United States
-
DermEffects
London, Ontario, N6H5L5, Canada
-
First OC Dermatology Research
Fountain Valley, California, 92708, United States
-
Klinika Ambroziak Dermatologia
Warsaw, 02-953, Poland
-
Paddington Testing Co.
Philadelphia, Pennsylvania, 19103, United States
-
Panstwowy Instytut Medyczny Ministerstwa Spraw Wewnetrznych
Warsaw, 02-507, Poland
-
Sadick Research Group
New York, New York, 10075, United States
-
TCR Medical Corporation
San Diego, California, 92123, United States
-
UK-SH - Lübeck
Lübeck, Schleswig-Holstein, 23538, Germany
-
Universitätsklinikum Carl Gustav Carus
Dresden, Saxony, 01307, Germany
-
Universitätsmedizin Mainz
Mainz, Hesse, 55131, Germany
-
Uniwersytecki Szpital Kliniczny im. F.Chopina w Rzeszowie
Rzeszów, 35-055, Poland
Conditions
Explore the condition pages connected to this study.